Immunovant Cash Flow Statement (2018-2026) | IMVT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-30.47M	-37.70M	-41.38M	-47.17M	-40.37M	-47.93M	-63.23M	-59.43M	-73.94M	-58.66M	-51.42M	-75.32M	-87.15M	-109.12M	-111.12M	-106.45M	-120.61M	-126.50M	-110.64M	-147.84M
Depreciation and Depletion (Quarter)	0.03M	0.03M	0.03M	0.04M	0.04M	0.05M	0.05M	0.05M	0.05M	0.06M	0.06M	0.06M	0.08M	0.09M	0.10M	0.11M	0.11M	0.10M	0.10M	0.10M
Share-based Compensation (Quarter)	3.86M	8.36M	10.16M	11.86M	7.69M	8.16M	8.91M	7.55M	10.69M	10.53M	10.22M	9.68M	13.46M	12.69M	11.65M	11.69M	18.51M	13.36M	12.71M	11.14M
Gains from Investment Securities (Quarter)	-0.57M	-0.17M	0.74M	0.13M										8.07M	-0.53M	0.20M	1.36M	-0.17M	0.04M	-1.30M
Asset Writedowns and Impairment (Quarter)
Cash from Operations (Quarter)	-21.21M	-20.05M	-31.89M	-32.96M	-65.82M	-20.19M	-46.40M	-55.79M	-47.37M	-60.06M	-47.10M	-59.70M	-76.20M	-88.65M	-100.39M	-110.64M	-117.41M	-102.52M	-92.33M	-95.06M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.27M	0.28M	0.28M	0.28M	0.28M	0.28M	0.28M	0.29M	0.29M	0.29M	0.29M	0.25M	0.07M	0.02M	0.02M	0.02M	0.02M	0.02M	0.03M	0.03M
Depreciation & Amortization (CF) (Quarter)	0.03M	0.03M	0.03M	0.04M	0.04M	0.05M	0.05M	0.05M	0.05M	0.06M	0.06M	0.06M	0.08M	0.09M	0.10M	0.11M	0.11M	0.10M	0.10M	0.10M
Change in Working Capital
Change in Receivables (Quarter)	0.21M	0.18M	7.53M	3.71M	0.95M	-9.76M	-2.94M	-0.00M	0.14M	0.56M	-0.27M	4.14M	-2.93M	-0.42M	0.20M	-0.09M	-0.13M	0.03M	-0.32M	-0.56M
Change in Account Payables (Quarter)	0.68M	1.14M	-0.43M	14.87M	-17.48M	6.52M	6.47M	-12.63M	25.01M	-18.91M	-3.70M	3.39M	3.88M	9.37M	-0.26M	-2.30M	-9.40M	-1.06M	1.56M	-1.35M
Change in Accured Expenses (Quarter)	1.17M	6.73M	8.29M	-6.72M	-5.54M	4.18M	2.63M	-1.12M	-17.29M	8.53M	-5.34M	15.46M	-7.54M	10.67M	4.15M	-7.02M
Change in Taxes (Quarter)
Investing Activities
Capital Expenditures (Quarter)	0.02M	0.04M	0.07M	0.12M	0.04M	0.03M	0.10M	0.03M	0.04M	0.03M	0.13M	0.15M	0.18M	0.20M	0.18M	0.20M				0.01M
Cash from Investing Activities (Quarter)	-0.02M	-0.04M	-0.07M	-0.12M	-0.04M	-0.03M	-0.10M	-0.03M	-0.04M	-0.03M	-0.13M	-0.15M	-0.18M	-0.20M	-0.18M	-0.20M				-0.01M
Financing Activities
Other financing activities (Quarter)																0.32M				-0.08M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Long-Term Debt Repayments (Quarter)
Short-Term Debt repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)		0.13M	-0.13M		0.02M		0.40M	0.23M	0.89M	0.15M	3.11M	1.54M	0.69M	0.73M	2.46M	0.93M	2.92M	24.59M	516.68M	495.69M
Misc.
Cash from Financing Activities (Quarter)	0.09M	200.04M			0.02M		70.63M	0.23M	0.89M	0.15M	469.84M	1.54M	0.69M	0.73M	2.46M	450.61M	2.92M	24.59M	564.60M	3.64M
Exchange Rate Effect (Quarter)			0.02M	-0.11M	-0.77M	-1.22M	2.70M	-0.49M	-0.05M	-0.09M	-1.61M	2.73M	0.34M	1.05M	-0.15M	-0.49M	-0.57M	0.88M	0.38M	-0.99M
Change in Cash (Quarter)	-21.14M	179.95M	-31.95M	-33.19M	-66.61M	-21.43M	26.84M	-56.08M	-46.57M	-60.03M	421.01M	-55.57M	-75.36M	-87.06M	-98.26M	339.29M	-115.06M	-77.04M	472.65M	-92.42M
Beginning Cash Balance (Quarter)
Free Cash Flow (Quarter)	-21.23M	-20.09M	-31.97M	-33.07M	-65.86M	-20.22M	-46.49M	-55.82M	-47.41M	-60.09M	-47.23M	-59.85M	-76.38M	-88.84M	-100.57M	-110.84M	-117.41M	-102.52M	-92.33M	-95.07M
Net Cash Flow (Quarter)	-21.14M	179.95M	-31.97M	-33.07M	-65.84M	-20.22M	24.14M	-55.59M	-46.52M	-59.95M	422.62M	-58.30M	-75.69M	-88.11M	-98.11M	339.77M	-114.49M	-77.92M	472.28M	-91.43M

Research Tools

Developers

Immunovant Cash Flow Statement (2018-2026) | IMVT

Research Tools

Developers

Immunovant Cash Flow Statement (2018-2026) | IMVT

Create an account

Sign In

Reset Password